Kintara Therapeutics, Inc.Kintara Therapeutics, Inc.Kintara Therapeutics, Inc.

Kintara Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪11.63 M‬USD
−4.0797USD
‪−14.65 M‬USD
‪55.30 M‬
Beta (1Y)
−14.95

About Kintara Therapeutics, Inc.

CEO
Robert E. Hoffman
Headquarters
San Diego
Employees (FY)
17
Founded
2009
FIGI
BBG00PZGK4G2
Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.